Advances in lung transplantation: The year in review

Journal of Heart and Lung Transplantation

Volumn 30, Issue 3, 2011, Pages 247-251

  Dilling, Daniel F ^a   Glanville, Allan R ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; INFECTION; LUNG TRANSPLANTATION; MEDLINE; ORGAN DONOR; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; SURGICAL TECHNIQUE;

EID: 79551687963     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.12.005     Document Type: Editorial

References (45)

1. J.D. Christie, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heartlung transplantation report2009 J Heart Lung Transplant 28 2009 1031 1049
2. E.S. Weiss, J.G. Allen, and R.A. Meguid The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases Ann Thorac Surg 88 2009 1062 1070
3. G. Thabut, J.D. Christie, and W.K. Kremers Survival differences following lung transplantation among US transplant centers JAMA 304 2010 53 60
4. C.A. Merlo, E.S. Weiss, and J.B. Orens Impact of U.S. Lung Allocation Score on survival after lung transplantation J Heart Lung Transplant 28 2009 769 775
5. M.J. Russo, A. Iribarne, and K.N. Hong High lung allocation score is associated with increased morbidity and mortality following transplantation Chest 137 2010 651 657
6. M. Cypel, M. Liu, and M. Rubacha Functional repair of human donor lungs by IL-10 gene therapy Sci Transl Med 2009 1 4ra9
7. H. Oishi, Y. Okada, and T. Kikuchi Transbronchial human interleukin-10 gene transfer reduces acute inflammation associated with allograft rejection and intragraft interleukin-2 and tumor necrosis factor-alpha gene expression in a rat model of lung transplantation J Heart Lung Transplant 29 2010 360 367
8. M. Cypel, M. Rubacha, and J. Yeung Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation Am J Transplant 9 2009 2262 2269
9. M. Cypel, M. Sato, and E. Yildirim Initial experience with lung donation after cardiocirculatory death in Canada J Heart Lung Transplant 28 2009 753 758
10. R.V. Venkateswaran, V. Dronavalli, and P.A. Lambert The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy Transplantation 88 2009 582 588
11. G.S. Dhillon, J. Levitt, and H. Mallidi Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network for Organ Sharing Database Transplantation 88 2009 842 846
12. J.G. Allen, E.S. Weiss, and C.A. Merlo Impact of donorrecipient race matching on survival after lung transplantation: analysis of over 11,000 patients J Heart Lung Transplant 28 2009 1063 1071
13. D.J. Lederer, J.S. Wilt, and F. D'Ovidio Obesity and underweight are associated with an increased risk of death after lung transplantation Am J Respir Crit Care Med 180 2009 887 895
14. G. Izbicki, I. Ben-Dor, and D. Shitrit The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor? Respir Med 103 2009 1346 1349
15. K.L. Vandemheen, A. O'Connor, and S.C. Bell Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation Am J Respir Crit Care Med 180 2009 761 768
16. E.S. Weiss, J.G. Allen, and C.A. Merlo Survival after single versus bilateral lung transplantation for high-risk patients with pulmonary fibrosis Ann Thorac Surg 88 2009 1616 1625
17. G. Thabut, J.D. Christie, and P. Ravaud Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis Ann Intern Med 151 2009 767 774
18. S.M. Kawut, J. Okun, and D. Shimbo Soluble P-selectin and the risk of primary graft dysfunction after lung transplantation Chest 136 2009 237 244
19. R.K. Braun, M. Molitor-Dart, and C. Wigfield Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection Transplantation 88 2009 1341 1348
20. Y. Yamada, Y. Sekine, and S. Yoshida Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts J Immunol 183 2009 237 245
21. H.E. Merry, P.S. Wolf, and E. Fitzsullivan Lipopolysaccharide pre-conditioning is protective in lung ischemiareperfusion injury J Heart Lung Transplant 29 2010 471 478
22. L.A. Danziger-Isakov, S. Husain, and M.L. Mooney The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation J Heart Lung Transplant 28 2009 1341 1347
23. O. Manuel, D. Lien, and J. Weinkauf Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology J Heart Lung Transplant 28 2009 1231 1236
24. P. Jaksch, B. Zweytick, and H. Kerschner Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy J Heart Lung Transplant 28 2009 670 675
25. S.M. Palmer, A.P. Limaye, and M. Banks Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial Ann Intern Med 152 2010 761 769
26. L.D. Snyder, C.A. Finlen-Copeland, and W.J. Turbyfill Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation Am J Respir Crit Care Med 181 2010 1391 1396
27. D. Kumar, S. Husain, and M.H. Chen A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients Transplantation 89 2010 1028 1033
28. M.R. Celik, D.J. Lederer, and J. Wilt Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study J Heart Lung Transplant 28 2009 697 703
29. A.R. Glanville Antibody-mediated rejection in lung transplantation: myth or reality? J Heart Lung Transplant 29 2010 395 400
30. A. Golocheikine, D.S. Nath, and H.I. Basha Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients J Heart Lung Transplant 29 2010 410 416
31. W. Jungraithmayr, P. Vogt, and I. Inci A model of chronic lung allograft rejection in the rat Eur Respir J 35 2010 1354 1363
32. M. Sato, S. Keshavjee, and M. Liu Translational research: animal models of obliterative bronchiolitis after lung transplantation Am J Transplant 9 2009 1981 1987
33. B. Banerjee, A. Kicic, and M. Musk Successful establishment of primary small airway cell cultures in human lung transplantation Respir Res 10 2009 99
34. E.A. Kastelijn, C.H. van Moorsel, and G.T. Rijkers Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation J Heart Lung Transplant 29 2010 665 671
35. E.A. Kastelijn, C.H. van Moorsel, and H.J. Ruven Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation J Heart Lung Transplant 29 2010 680 686
36. N. Angaswamy, D. Saini, and S. Ramachandran Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation Hum Immunol 71 2010 560 565
37. L.A. Borthwick, S.M. Parker, and K.A. Brougham Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation Thorax 64 2009 770 777
38. P.R. Burton, B. Button, and W. Brown Medium-term outcome of fundoplication after lung transplantation Dis Esophagus 22 2009 642 648
39. R. Jain, R.R. Hachem, and M.R. Morrell Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome J Heart Lung Transplant 29 2010 531 537
40. E.S. Weiss, J.G. Allen, and C.A. Merlo Factors indicative of long-term survival after lung transplantation: a review of 836 10-year survivors J Heart Lung Transplant 29 2010 240 246
41. D. Thomsen, and B.O. Jensen Patients' experiences of everyday life after lung transplantation J Clin Nurs 18 2009 3472 3479
42. C.S. King, S. Khandhar, and N. Burton Native lung complications in single-lung transplant recipients and the role of pneumonectomy J Heart Lung Transplant 28 2009 851 856
43. L. Gullestad, M. Iversen, and S.A. Mortensen Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial Transplantation 89 2010 864 872
44. H.C. Ott, B. Clippinger, and C. Conrad Regeneration and orthotopic transplantation of a bioartificial lung Nat Med 16 2010 927 933
45. T.H. Petersen, E.A. Calle, and L. Zhao Tissue-engineered lungs for in vivo implantation Science 329 2010 538 541